Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Fortis Healthcare,...

    Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI

    Farhat NasimWritten by Farhat Nasim Published On 2018-12-22T11:02:58+05:30  |  Updated On 22 Dec 2018 11:02 AM IST
    Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI

    Markets regulator Sebi Friday directed Fortis Healthcare and Fortis Hospitals to take necessary steps to recover Rs 403 crore, along with interest, from Shivinder Mohan Singh, Malvinder Mohan Singh and seven other entities within three months.





    New Delhi: Markets regulator Sebi Friday directed Fortis Healthcare and Fortis Hospitals to take necessary steps to recover Rs 403 crore, along with interest, from Shivinder Mohan Singh, Malvinder Mohan Singh and seven other entities within three months. The Sebi, through an order passed in October this year, had asked Fortis Healthcare to recover the amount.


    The fresh order comes after the two companies made representation to the markets regulator.

    In the submission to Sebi, the firms said that the recovery of the outstanding amount should be carried out by Fortis Hospitals (FHsL)instead of Fortis Healthcare (FHL), which would ensure that such sums are actually recovered and reflected in the balance sheet of Fortis Hospitals.

    "The outstanding amount of Rs 403 crore ... had been advanced by FHsL itself to Best, Fern and Modland. As such, the outstanding amount is required to be returned to FHsL itself. Since the loan of the outstanding amount had been made solely by FHsL, on its own account, upon recovery of the outstanding amount by FHsL, there would not be any consequent requirement upon FHsL to pay the same to FHL.

    "Consequently, FHsL and not FHL would be the relevant entity which would be required to take steps for the recovery of the outstanding amount," as per the submission.

    FHsL is a 100 per cent wholly-owned subsidiary of FHL.

    Noting that the two firms have cited reasons and grounds which are prima facie sufficient for modifying the directions issued through the interim order, Sebi said, "FHL and FHsL shall take all necessary steps to recover the...amount of Rs 403 crore (approx.) along with due interest from noticee (Singh brothers and seven other entities)... within three months from the date of the interim order".

    It further said that Singh brothers, RHC Holdings, Religare Finvest, Shivi Holdings, Malav Holdings, Best Healthcare, Fern Healthcare and Modland Wears will have to jointly and severally, repay the amount.


    Earlier, Fortis Hospitals was also required to repay the amount.

    The regulator has barred Singh brothers from associating themselves with the affairs of Fortis Healthcare and Fortis Hospitals in any manner whatsoever, till further directions.

    These entities, prima facie, acted in a fraudulent manner in diverting funds around Rs 403 crore from Fortis Healthcare Ltd, a listed company, for the ultimate benefit of parent company RHC Holding and group company Religare Finvest Ltd, violating the securities laws, Sebi said in the interim order.





    Also Read: Yes Bank sells over 2% stake in Fortis Healthcare

    FHLFortisFortis Healthcarehospital chainsIHH HealthcareMalvinder Mohan SinghSEBISecurities and Exchange Board of IndiaShivinder Mohan SinghSingh brothersstakeSupreme CourtYes Bank
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok